Nothacker Monika
AWMF-Institut für Medizinisches Wissensmanagement, c/o Philipps Universität Marburg, Karl-von-Frisch-Str. 1, 35043, Marburg, Deutschland.
Urologe A. 2021 Apr;60(4):455-464. doi: 10.1007/s00120-021-01493-w. Epub 2021 Mar 19.
To justify clinical guideline recommendations comprehensibly is challenging. It is a matter of presenting the quality of the published evidence concerning its certainty and patient relevance, but also additional reasons for the grade of recommendation, as the strength of the recommendation does not only reflect the strength of the evidence. To state this reasoning in a structured manner, an "Evidence to Decision Framework" was developed. In addition to an evaluation of benefits and harms as well as information on certainty of the evidence, the framework comprises further criteria as patient preferences, acceptance of professional stakeholders, feasibility, equity and resources and costs. The most important arguments to justify recommendations in exemplary analyzed urological guidelines are the balance of benefits and harms and the appraisal of the certainty of the underlying evidence; in some cases, patient preferences are addressed. Whether there is an added value in applying further decision criteria for the development and implementation of guidelines remains to be verified. An opportunity of S3 guidelines (evidence- and consensus-based, 6/17 urological guidelines) is that knowledge gaps can be systematically identified, which enables the formulation of relevant research questions, which may contribute to a better basis for future recommendations.
全面论证临床指南建议具有挑战性。这不仅涉及展示已发表证据的质量及其确定性和与患者的相关性,还涉及推荐等级的其他理由,因为推荐强度不仅反映证据强度。为了以结构化方式阐述这一推理过程,人们开发了一个“证据到决策框架”。除了对获益与危害进行评估以及提供证据确定性信息外,该框架还包括患者偏好、专业利益相关者的接受度、可行性、公平性以及资源和成本等进一步标准。在对泌尿外科指南进行示例分析时,用于论证建议的最重要论据是获益与危害的平衡以及对基础证据确定性的评估;在某些情况下,也会考虑患者偏好。对于指南制定和实施而言,应用更多决策标准是否具有附加价值仍有待验证。S3指南(基于证据和共识,17部泌尿外科指南中的6部)的一个优势在于,可以系统地识别知识空白,从而能够提出相关研究问题,这可能有助于为未来的建议提供更好的基础。